Renin–angiotensin system inhibition in COVID-19 patients: Friend or foe?

Karadağ, Bilgehan

Journal Metrics

Impact Factor (2022): 1.3
5-Year Impact Factor: 1.5
Eigenfactor Score: 0.00148
CiteScore (2022): 1.9
SCImago Journal Rank: 0.29

28/4Current Issue Ahead of Print Archive Most Accessed Articles

Quick Search

In authors and institutes

In titles and abstracts

In keywords

In all

pdf

Renin–angiotensin system inhibition in COVID-19 patients: Friend or foe? [Anatol J Cardiol]

Anatol J Cardiol. 2020; 24(1): 30-31 | DOI: 10.14744/AnatolJCardiol.2020.40771

Renin–angiotensin system inhibition in COVID-19 patients: Friend or foe?

Bilgehan Karadağ
Department of Cardiology, Istanbul University Cerrahpaşa, School of Medicine; İstanbul-Turkey

Keywords: angiotensin, COVID-19, renin angiotensin system

Bilgehan Karadağ. Renin–angiotensin system inhibition in COVID-19 patients: Friend or foe?. Anatol J Cardiol. 2020; 24(1): 30-31

Corresponding Author: Bilgehan Karadağ, Türkiye
Manuscript Language: English

TOOLS Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Send email to author Similar articles PubMed Google Scholar